Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and safety of HCP1904-3 in essential hypertension have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HCP1904-3

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED